Skip to content
SentinelMarket desk
Switch to dark mode

씨티씨바이오

060590KOSDAQView the 제약 sectorTheme Bio & healthcare

2,855KRWMarket close of 10/20 (Tue)

Down -2.39%-70KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)2,820KRWDown -1.23%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
2,975
High
2,975
Low
2,830
Day range
Day range low 2,830 high 2,975, open 2,975, close 2,855, previous close 2,925
Volume
2×10K shares
58.22 million KRW 0.49× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 2,700 to 6,050 won, 5% up from the low

5% of the way up from the lowest close in 1 year (252 sessions) · -52.8% from the high

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range-2.39%-2.39%, 1.8× the usual (20-session average ±1.35%)
    That day -2.39% · usual ±1.35% · large-move threshold ±3.0%

The other 3 are within the usual range

  • Trading value0.5×usual range
  • EarningsOperating income, 8 quartersOperating income, 8 quarters
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue34.4B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +1.0%
    vs. prior quarter
    +53.4%
  • Operating income4.6B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +401.7%
    vs. prior quarter
    +185.0%
  • Operating margin13.4%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +10.7 pp
    vs. prior quarter
    +6.2 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-05-12
2021Q1 543.05 million KRW2026Q1 4.6B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.